Potential ways to enhance ADR reporting given current concerns: enhancing ADR reporting

Israel Sefah, Brian Godman

Research output: Contribution to journalEditorialpeer-review

9 Downloads (Pure)


In previous commentaries, we discussed potential ways to enhance the quality and efficiency of medicine use amongst all key stakeholder groups and across health‑care sectors.[1,2] We would now like to focus on adverse drug reactions (ADRs), which can be defined as harmful or unpleasant unintended reactions, resulting from the use of medicines occurring at doses normally used in man.[3,4] Adverse drug events (ADEs) are now commonly used as a wider term than ADRs, defined as an injury resulting from the use of a medicine; however, not necessarily causally related to that medicine.[3,5,6] ADEs incorporate a number of areas including ADRs, drug allergies, medication errors, and overdoses.
Original languageEnglish
Pages (from-to)137-140
Number of pages4
JournalAdvances in Human Biology
Issue number2
Publication statusPublished - 31 May 2021


  • adverse drug reactions
  • adverse drug events
  • health policy
  • interventions
  • under-reporting

Cite this